Remove 2015 Remove Leads Remove Pharma Remove Physicians
article thumbnail

How Pharma Companies Can – And Should – Improve Social Determinants of Health

Eversana Intouch

10 The more than 350 program initiatives address economic stability, education access/quality, health care access/quality, neighborhood/built environment and social/community context, 2 and focus on 23 high-priority leading health indicators (LHIs) that impact major causes of death and disease in the United States. August 2015.

Pharma 94
article thumbnail

Americans continue to neglect their health

World of DTC Marketing

As the NY Times recently reported , obesity is the leading cause of mortality in the United States. To date the AMA, insurers, pharma and physicians have done very little to fight the obesity epidemic. Obesity costs the nation $1.72 trillion every year. In the United States, where at least 4.6 And it’s getting worse.

Insurance 238
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Largest global clinical site hires all-female key leaders in Europe

European Pharmaceutical Review

The three new European hires are: Maria Lehretz, Medical Director, Velocity Leipzig, Germany Maria has nearly a decade of experience as a clinical research physician, and has worked on approximately 70 clinical trials. She was medical lead at SIBAmed GmbH for four years.

article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

CVS then began affiliating with health systems across the country (like Cleveland Clinic ) for physician oversight of MinuteClinic’s staffed midlevel providers, just as Walgreens was rising as a formidable competitor in the convenient care space through its own walk-in clinics that it launched in fall 2006. Key acquisitions by U.S.

article thumbnail

5 Core Tenets of HCP-focused Point-of-Care Marketing

PM360

The EHR is the Holy Grail of POC Messaging (At Least for Now) Reaching HCPs while they’re prescribing is the epitome of physician messaging. The Medical Literature Reports on POC Too; They Call it “Nudging” It’s not just pharma that’s interested in changing prescriber behavior. But this gradual expansion hasn’t always come easy.

article thumbnail

The evolving role of social media in healthcare

pharmaphorum

In recent years, social media has evolved into an essential part of pharma operations, for better or worse. Below, I’m exploring a few ways that pharma teams are using social media and other online collaboration platforms to connect, educate, and influence. Healthcare Provider (HCP) marketing. Congress Coverage.

Media 78
article thumbnail

Comparison of Humira biosimilars in the US and Europe

Pharmaceutical Technology

Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. Many pharma companies hold extensive patent protections and have ongoing patent litigation cases. The primary reasons for delayed market entry in the US revolve around patent disputes.